Deals
Sackler-Owned Mundipharma Taps Deutsche Bank for Sale
- Sale could help Sackler family raise $3 billion to $5 billion
- Business has drawn interest from drugmakers to buyout firms
This article is for subscribers only.
Mundipharma International Ltd., a global pharmaceutical company owned by the billionaire Sackler family, is working with Deutsche Bank AG as it weighs a sale of the business amid interest from potential buyers, people familiar with the matter said.
A sale of the Cambridge, U.K.-based business could fetch from $3 billion to $5 billion, the people said, asking not to be identified because the matter is private. The company has attracted initial interest from other pharmaceutical companies as well private equity firms, the people said.